ZUBRIN 200 ANTI-INFLAMMATORY TABLETS FOR DOGS
국가: 오스트레일리아
언어: 영어
출처: APVMA (Australian Pesticides and Veterinary Medicines Authority)
환자 정보 전단 유효 성분:
TEPOXALIN
제공처:
INTERVET AUSTRALIA PTY LIMITED
INN (International Name):
tepoxalin(200mg/Tb)
약제 형태:
ORAL TABLET
구성:
TEPOXALIN UNGROUPED Active 200.0 mg/Tb
패키지 단위:
10 Tablets; 30 Tablets; 60 Tablets
수업:
VM - Veterinary Medicine
Manufactured by:
INTERVET AUSTRALIA
치료 그룹:
DOG | BITCH | CASTRATE | PUPPY
치료 영역:
MUSCULOSKELETAL SYSTEM
치료 징후:
ANTI-INFLAMMATORY AGENT | MUSCULOSKELETAL CONDITIONS | ANTIPYRETIC | ARTHRITIS | ARTHROSIS | BONE SORENESS | BRUISING | BURSITIS | EXTERNAL MYOPATHY | INFLAMATION OF SOFT TISSUES AN | INFLAMMATORY RHEUMATIC ARTHRIT | JOINT DISEASE | LIGAMENT SPRAINS | MUSCLE SORENESS | OSTEITIS | OSTEOARTHRITIS | PLATELET ACTIVITY | RHEUMATISM | SPRAINS | STRAINS | TENDON AND LIGAMENT SPRAINS | TENDON SPRAINS | TENDONITIS | TENOSYNOVITIS | TRAUMATIC JOINT AND CONNECTIVE | TRAUMATIC SWELLING
제품 요약:
Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG: [ANTI-INFLAMMATORY AGENT, MUSCULOSKELETAL CONDITIONS]; Poison schedule: 4; Withholding period: ; Host/pest details: DOG: [ANTI-INFLAMMATORY AGENT, MUSCULOSKELETAL CONDITIONS]; A non steroidal anti inflammatory for the reduction of inflammation and relief of pain associated with musculoskeletal disorders in dogs.
승인 상태:
Registered
승인 날짜:
2023-07-01
제품 특성 요약
________________________________________________________________________
Schering-Plough Corporation
Global Supply Chain
1095 Morris Avenue
Union, New Jersey 07083-7143
Telephone (908) 298-4000
ZUBRIN
RAPIDLY-DISINTEGRATING TABLETS
(EX000034)
This product is exempt from [Material] Safety Data Sheet requirements.
The following regional exemptions apply:
United States:
According to the OSHA Hazard Communication Standard [29 CFR §
1910.1200 (b) (6) (vii)], an MSDS is
not required for any drug when it is in the solid, final form (_e.g_.
tablets or pills).
European Union:
According to the European Union Commission Directive 2001/58/EC of 27
July 2001, as it relates to
Directive 1999/45/EC [Article 1.5.a], an SDS is not required for
medicinal products in the finished state,
intended for the final user.
Canada:
According to the WHMIS Hazardous Product Act [Part II Controlled
Products 12.b], an MSDS is not
required for any drug within the meaning of the _Food and Drugs Act._
If you have any questions or need assistance, please call
Schering-Plough Animal Health
Corporation at 800- 932-0473. Many Schering-Plough Animal Health
[Material] Safety Data
Sheets may be obtained through the MSDS HelpLine at 800-770-8878 or
from the S-P MSDS
website at www.schering-ploughmsds.com.
Technical inquiries for adverse events in animals for Schering-Plough
Animal Health Products may
be addressed to Schering-Plough Animal Health Technical Services:
For Small Animals and Horses (800) 224-5318
For Livestock (800) 211-3573
For Poultry (800) 219-9286
Sincerely,
Global Safety & Environmental Affairs
Schering-Plough Corporation
Schering-Plough
Global Safety & Environmental Affairs
전체 문서 읽기
